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1. Introduction 
In this chapter we begin to study the effect of the antibacterial agents used for control of 
microbial growth  
There are some essential related terms for studying the antibacterial agents that are 
mentioned as in following: 
a. Biocide: A widespread chemical or physical agent which inactivates microorganisms.  
b. Bacteriostatic: property of  a specific biocide agent which is able to bacterial 
multiplication. 
c. Bactericidal: A specific term referring to the property by which a biocide is able to kill 
bacteria.  
d. Disinfectants: Products or biocides used to reduce only the number of viable 
microorganisms on the inanimate objects 
e. Septic: Characterized by the presence of pathogenic microbes in living tissue. 
f. Antiseptic: A biocide or product that inhibits the growth of microorganisms in or on 
living tissue. 
g. Aseptic: Free of or using methods to keep free of, microorganisms. 
h. Antibiotics: Naturally occurring or synthetic organic compounds which inhibit or 
destroy selective bacteria, generally at low concentrations. 
i. Sterilization: is defined as the process where all the living microorganisms, including 
bacterial spores are killed. Sterilization can be achieved by physical, chemical and 
physiochemical means.  
j. Asepsis is the employment of techniques (such as usage of gloves, air filters, uv rays 
etc) to achieve microbe-free environment. 
Large numbers of antibacterial agents are of clinical interest. The mechanisms by which 
compounds with antibacterial activity inhibit growth or cause bacterial death are varied and 
depend on the affected targets. Some strategies of antibacterial agents are introduced as 
following: 
Damage to DNA 
Ultraviolet light, ionizing radiations and DNA-reactive chemicals are example of physical 
and chemical agents that act by damaging DNA. Among the DNA-reactive chemicals, 
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alkylating agents react covalently with purine and pyrimidine bases to form DNA 
interstrand cross-links. Ultraviolet light, for example, induces cross-linking between 
adjacent pyrimidines on one or the other of the two polynucleotide strands, forming 
pyrimidine dimers; ionizing radiations produce breaks in single and double strands.  
Protein denaturation 
The tertiary structure of the protein is readily disrupted by a number of physical or chemical 
agents, causing the protein to become nonfunctional. The disruption of the tertiary structure 
of a protein is called protein denaturation. A range of antibacterial agents inhibit the 
translation of the messenger RNA (mRNA) chain into its corresponding peptide chain.  
Disruption of cell membrane  
The cell membrane is known as a selective barrier, allowing some solutes to pass through and 
excluding others. Some bactericidal agents may alter the physical and chemical properties of 
the membrane, preventing its normal functions and therefore killing or inhibiting the cell. The 
structure of the cytoplasmic membranes in bacterial cells can be readily disrupted by certain 
agents. Polymyxins are the most important antibiotics which act on the membranes of Gram-
negative bacteria. Amphotericin B and Nystatin are other toxic molecules named as polyene 
antifungal agents which have inhibitory action on membrane function  
Disruption of cell wall 
Destroying or preventing the synthesis of cell wall occurred after exposure to agents such as 
Lysozyme and Penecillin, respectively. The disruption of the cell wall may cause the cell 
lysis. 
Synthesis of peptidoglycan precursors starts in the cytoplasm; wall subunits are then 
transported across the cytoplasmic membrane and finally inserted into the growing 
peptidoglycan molecule. Several different stages are therefore potential targets for 
inhibition. β-lactams , Bacitracin and Cycloserines  are inhibitors of synthesis of 
peptidoglycan . β-lactams are the most important and the glycopeptides which are active 
only against Gram-positive bacteria. Cycloserines mainly used as a 'second-line' medication 
for treatment of tuberculosis, discussed later in this chapter have many fewer clinical 
applications. 
Removal of free sulfhydryl groups 
A large number of the antibiotics have demonstrated chemical reactivity toward compounds 
containing sulfhydryl groups. There have also been observed marked differences in 
reactivity of individual antibiotics toward various types of sulfhydryl-containing 
compounds.  
Enzyme proteins containing cysteine have side chains terminating in sulfhydryl groups. In 
addition to these, coenzymes such as coenzyme A and dihydrolipoate contain free 
sulfhydryl groups. Such enzymes and coenzymes cannot function unless the sulfhydryl 
groups remain free and reduced. Oxidizing agents thus interfere with metabolism by 
forming disulfide linkages between neighboring sulfhydryl groups. 
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The most widespread methods used for controlling microorganism are the application of 
chemical and physical agents. 
The most widely used physical methods include heat, radiation, and filtration which can 
destroy or remove undesirable microorganisms. Here we discuss how these methods work 
and discuss some practical examples. 
Heat 
One of the simplest means of sterilization is heat.  Heat acts by oxidative effects as well as 
denaturation and coagulation of proteins. Those articles that cannot withstand high 
temperatures can still be sterilized at lower temperature by prolonging the duration of 
exposure. Dry heat acts by protein denaturation, oxidative damage and toxic effects of 
elevated levels of electrolytes. The moist heat acts by coagulation and denaturation of 
proteins. Moist heat is superior to dry heat in action. Temperature required to kill microbe 
by dry heat is more than the moist heat. The minimum time required to kill a suspension of 
organisms at a predetermined temperature in a specified environment is known as Thermal 
death time. 
A temperature of 100°C will kill all bacteria, but in laboratory-scale cultures, within 2–3 
minutes; a temperature of 121°C for 15 minutes whit 15 pound per inch is utilized to kill 
spores.  
Radiation 
Two types of radiation are used, ionizing and non-ionizing. Non-ionizing rays are low 
energy rays with poor penetrative power while ionizing rays are high-energy rays with 
good penetrative power. 
Non-ionizing rays: Rays of wavelength longer than the visible light are non-ionizing. 
Microbicidal wavelength of UV rays lie in the range of 200-280 nm, with 260 nm being the 
most effective. UV rays are generated using a high-pressure mercury vapor lamp. It is at this 
wavelength that the absorption by the microorganisms is at its maximum, which results in 
the germicidal effect. UV rays induce formation of thymine-thymine dimers, which 
ultimately inhibit DNA replication. UV readily induces mutations in cells irradiated with a 
non-lethal dose. Microorganisms such as bacteria, viruses, yeast that are exposed to the 
effective UV radiation are inactivated within seconds. Since UV rays don’t kill spores, they 
are considered to be of use in surface disinfection. UV rays are employed to disinfect 
hospital wards, operation theatres, virus laboratories, corridors, etc.  
Ionizing rays: Ionizing rays are of two types, particulate and electromagnetic rays. 
Electron beams are particulate in nature while gamma rays are electromagnetic in nature. 
High speed electrons are produced by a linear accelerator from a heated cathode. Electron 
beams are employed to sterilize articles like syringes, gloves, dressing packs, foods and 
pharmaceuticals. 
Sterilization is accomplished in few seconds. Unlike electromagnetic rays, the instruments 
can be switched off. 
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Filtration 
In the filtration method microbes do not kill, it just separates them out. Membrane filters 
with pore sizes between 0.2-0.45 μm are commonly used to remove particles from solutions 
that can't be autoclaved.  
Various applications of filtration include removing bacteria from ingredients of culture 
media, preparing suspensions of viruses and phages free of bacteria, measuring sizes of 
viruses, separating toxins from culture filtrates, counting bacteria, clarifying fluids and 
purifying hydrated fluid. Different types of filters are Earthenware filters, Asbestos filters, 
Sintered glass filters, Membrane filters and Air Filters. 
The other antimicrobial agents are those chemicals which destroy pathogenic bacteria from 
inanimate surfaces. They are listed in the table (1). 
 
Chemical Mode of action Uses 
Alcohols 
Denaturing  proteins and 
 Solublizing  lipids 
Antiseptic used on skin 
Formaldehyde (8%) 
Reacting  with NH2, SH and 
COOH groups 
Disinfectant, kills endospores 
Tincture of Iodine Inactivating the proteins 
Antiseptic used on skin 
Disinfection of drinking water 
Chlorine (Cl2) gas 
Formation of  hypochlorous 
acid (HClO), a strong 
oxidizing agent 
Disinfect drinking water; 
general disinfectant 
Heavy metals Inactivating the proteins 
Disinfection of skin and 
laboratories  
Mercuric chloride 
Inactivation of  proteins by 
reacting with sulfide groups 
Disinfectant, although 
occasionally used as an 
antiseptic on skin 
Detergents Disruption of cell membranes  
Skin antiseptics and 
disinfectants 
Ethylene oxide gas Alkylating agent 
Disinfectant used to sterilize 
heat-sensitive objects such as 
rubber and plastics 
Ozone 
Produces lethal oxygen 
radicals 
Purification of water, sewage 
Phenols decreasing the surface tension 
Disinfection of  laboratory 
devices, toilet and recycle bin 
Table 1. Chemical antibacterial agents  
Antibiotics fight against bacteria by inhibiting certain vital processes of bacterial cells or 
metabolism. Based on these processes, we can divide antibiotics into five major classes: 
1. Cell wall inhibitors, such as Penicillin and Vancomycin. 
2. Inhibitors of cell membrane function, such as Polymyxin B and Daptomycin. 
3. Protein synthesis inhibitors, such as Aminoglycoside.  
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4. Inhibitors of nucleic acid synthesis, such as Fluoroquinolones, which inhibits DNA 
synthesis, and Rifampin, which inhibits RNA synthesis. 
Inhibition of cell wall synthesis 
The cell wall contains chemically distinct polysaccharides. The polysaccharides contain the 
amino sugars N-acetyl glucosamine (GlcNAc) and acetylmuramic acid (MurNAc). All β-
lactam drugs are selective inhibitors of bacterial cell wall synthesis and therefore active 
against growing bacteria.   
The bacterial cell wall-a unique structure in most bacteria can be affected in several ways: at 
different stages of synthesis (Fosfomycin, Cycloserine) or transport (Bacitracin, 
Mureidomycins) of its metabolic precursors, or by a direct action on its structural 
organization (β-lactams, Glycopeptides). The initial step in drug action is binding of the 
drug to cell receptors (Penicillin-binding proteins; PBPs). β-lactam drugs act as a false 
substrate for D-alanyl-D-alanyl transpeptidases , so they inhibit the transpeptidation 
reaction and peptidoglycan synthesis. In the next step, inhibitor of autolytic enzymes in the 
cell wall is inactivated. This activates the lytic enzyme and results in lysis if the environment 
is isotonic. So, β-lactam drugs are only active against rapidly dividing bacteria and growth 
lag phase ones are more stable to cell wall synthesis inhibitors.  
Penicillins, Cephalosporins, Vancomycin, and Cycloserine inhibit the cell wall synthesis. 
Several other drugs, including Bacitracin, Teicoplanin, Vancomycin, Ristocetin, and 
Novobiocin, inhibit early steps in the biosynthesis of the peptidoglycan. In an effective 
inhibitory mechanism these drugs must be penetrated in the early stages of the cell wall 
synthesis took place inside the cytoplasmic membrane. In the case of Glycopeptides such as 
Vancomycin and Teicoplanin, attachments to D-ALA-D-ALA terminal end of peptidoglycan 
precursors occur. This inhibits the action of transglycosidase and transpeptidases, resulting 
in cell wall impairment. 
The difference in susceptibility of gram-positive and gram-negative bacteria to various 
Penicillins or Cephalosporins would be attributed to the structural differences in their cell 
walls. Transpeptidases are located in periplasmic space that is directly accessible in gram-
positive bacteria but not in Gram-negatives; so, theses drugs need to cross the outer bacterial 
cell membrane of Gram-negatives (passive diffusion) or pass through porin channels.  
Some factors (eg, amount of peptidoglycan, presence of receptors and lipids, nature of cross-
linking, activity of autolytic enzymes) affect the penetration, binding and activity of the 
drugs 
Inhibition of cell membrane function 
The cytoplasmic membrane is a selective permeability barrier, carries out active transport 
functions, and thus controls the internal composition of the cell. Macromolecules and ions 
can escape from the membrane as a result of cytoplasmic membrane disruption or cell 
damage. The cytoplasmic membrane of bacteria and fungi is more rigid than animal or plant 
cells and can be disrupted by certain agents. Consequently, selective chemotherapy is 
suggested. 
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Amphotericin B, Colistin, Ionospheres, Daptomycin , the Imidazoles and Triazoles are other 
examples of agents which inhibit the function of cell membrane. The detail mechanisms of 
action of other cell membrane inhibitors are shown in the table (2). 
Inhibition of protein synthesis 
Protein synthesis can be blocked by a large variety of compounds that affect any of the 
phases of this process, including activation (Mupirocin), initiation (Oxazolidinones, 
Aminoglycosides), binding of the tRNA amino acid complex to ribosomes (Tetracyclines, 
Glycylcyclines) and elongation (Amphenicols, Lincosamides, Macrolides, Ketolides, 
Streptogramins, Fusidic acid). In  details, Tetracycline, Minocycline and Doxycycline, 
reversibly bind to the 30S subunit of ribosome and inhibit binding of aminoacyl-t-RNA to 
the acceptor site (A-site) on the 70S ribosome. Aminoglycosides also, bind to the A-site of 
the 30S subunit (the equivalent of mammalian 40S subunit) in an energy dependent process. 
In contrast to Tetracycline, the binding  of Aminoglycosides to the A-site of the 30S subunit 
is irreversible. This mode of action means that Aminoglycosides act as bactericidal agents 
while Tetracycline belong to bacteriostatic agent group. This frustrating binding, freeze the 
30S initiation complex (30S-mRNA-tRNA), disturbs elongation of the peptide chain. At the 
second step, aminoglycosides impair translational accuracy that finally lead to misreading 
of the mRNA sequence and/or premature termination of protein synthesis.  
On the other hand, the large subunit of bacterial ribosomes (the equivalent of mammalian 
60S subunit) occupied by Macrolides and some non-macrolides such as Chloramphenicol 
and Lincosamides. Premature dissociation of peptidyl tRNA from ribosome during 
elongation process occurred base on the attachment to 23S rRNA of the 50S ribosomal 
subunit. Consequently, peptidyl tRNA translocation from A to P site inhibited and peptide 
bond formation would be blocked; so, truncated peptide would be released after that. 
Similar mechanism is used by Lincosamides (Lincomycin and Clindamycin) that bind 50S 
subunit of ribosomes to inhibit protein synthesis.  
Protein synthesis is also inhibited by another Macrolide (erythromycin) with a completely 
different way. Erythromycin prevents assembly of 50S subunit and as a result, no functional 
ribosome emerged that could trigger protein synthesis. This mechanism is also used by a 
new class of synthetic antibacterials (Linezolid) that inhibit the formation of the initiation 
complex. 
Fusidic acid binds to elongation factor G (EF-G) and inhibits release of EF-G from the EF-
G/GDP complex. 
Rifampin, Rifamycin, Rifampicin bind to DNA-dependent RNA polymerase and inhibit 
initiation of RNA synthesis. 
Inhibition of nucleic acid synthesis 
Examples of drugs acting by inhibition of nucleic acid synthesis are the Quinolones, 
Pyrimethamine, Rifampin, Sulfonamides, Trimethoprim, and Trimetrexate. 
Nitroimidazoles, Nitrofurans affect DNA directly. Trimethoprim and Sulfamides block 
bacterial metabolic pathways. Some compounds are unable to kill bacteria but can block 
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bacterial mechanisms of resistance, enhancing the activity of other antimicrobials 
administered in combination. Among this group of agents, only certain β-lactamase 
inhibitors are currently in clinical use. 
All Quinolones and Fluoroquinolones inhibit microbial DNA synthesis by blocking DNA 
gyrase. 
In the following table are grouped characteristics of each class of antibiotics and mode of 
action. 
 
Class Example Mode of action 
Aminoglycoside Gentamicin,Tobramycin,Amikacin 
Bactericidal; inhibit 
protein synthesis 
β-lactam/β-
lactamase 
inhibitors 
Ampcillin-sulbacam, Ticaracillin-
clvulnate, Piperaciin-Tazobactam 
Bactericidal; inhibit cell 
wall synthesis 
Cephalosporin 
Cefotaxime,Ceftriaxone, Ceftazidime, 
Cefepime 
Bactericidal; inhibit cell 
wall synthesis  
Fluoroquinolone 
Levofloxacin, Ciprofloxacin, 
Moxifloxacin 
Bactericidal; block DNA 
replication 
Glycopeptide Vancomycin 
Bactericidal; inhibition of 
cell wall synthesis 
Glycylcycline Tigecycline 
Bacteriostatic; inhibit 
protein synthesis 
Macrolide 
Erythromycin,Clarithromucin, 
Azithromycin 
Bacteriostatic; inhibit 
protein synthesis 
Oxazolidinone Linezolid 
Bacteriostatic; inhibit 
protein synthesis 
Polymyxins Polymyxin B, Colistin 
Bactericidal; disrupt cell 
membrane 
Tetracycline 
Doxycycline, Tetracycline, 
Minocycline 
Bacteriostatic; inhibit 
protein synthesis 
Table 2. Antimicrobial agent classification and mode of action 
Resistance to antimicrobial drugs 
Infectious microorganisms can develop ways to exhibit resistance to drugs. This antibiotic 
resistance is due to the increasing use of antibiotics. There are many different mechanisms 
by which microorganisms can survive. Acquired resistance is often caused by mutations in 
chromosomal genes, or by the acquisition of mobile genetic elements, such as plasmids or 
transposons, which carry the antibiotic resistance genes. 
1. Production of destroying enzyme 
Organism may acquire genes encoding enzymes, such as β-lactamases, that destroy the 
antibacterial agent before it can have an effect. This enzyme destroys and inactivates the 
penicillin G drug. An important strategy of organisms for resistance to penicillins is due to 
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penicillin-destroying enzymes (β -lactamases).β -Lactamases disrupts the antimicrobial 
activity of penicillins and cephalosporins by opening the β -lactam ring. Some inhibitors that 
have a high affinity for β -lactamase are Clavulanic acid, sulbactam, and tazobactam. Gram-
negative bacteria produce some adenylylating, phosphorylating, or acetylating enzymes for 
resistant to aminoglycosides 
2. Altering the permeability of the drugs 
Bacteria may acquire efflux pumps that extrude the antibacterial agent from the cell before it 
can reach its target site and exert its effect. For example, changing the permeability of the 
drug (e.g Polymyxins) is one of the strategies of organism to exhibit resistance.  
3. Altering the structural target for the drug 
Bacteria may acquire several genes for a metabolic pathway which ultimately produces 
altered bacterial cell walls that no longer contain the binding site of the antimicrobial agent. 
Organisms which are resistant to erythromycin alter the receptor on the 50S subunit of the 
ribosome through methylation of a 23S ribosomal RNA. The loss or alteration of PBPs is 
another resistance mechanism of some drugs (e.g. Penicillins and Cephalosporins).  
4. Altering the metabolic pathway  
Some Sulfonamide-resistant bacteria do not require extracellular PABA but can utilize 
preformed folic acid. 
5. Altering the function of enzyme  
that can still perform its metabolic function but is much less affected by the drug. In 
Trimethoprim-resistant bacteria, the dihydrofolic acid reductase is inhibited far less 
efficiently than in trimethoprim-susceptible bacteria. 
Factors affecting antimicrobial activity 
Some antimicrobial agents are microbicidal under one set of conditions and microbistatic 
under others. Factors that influence the activity of antimicrobial agents are (1) the 
susceptibility of the microorganism, (2) the concentration or dose of the agent, (3) the length 
of exposure, (4) the number of microorganisms, and (5) environmental conditions. 
Microbial susceptibility 
Microbes vary in their response to different disinfectants. For example, vegetative cells of 
the Mycobacteria that cause tuberculosis and leprosy, however, are covered by a waxy 
coating that protects them from many antimicrobial chemicals. In addition, the hepatitis B 
virus and some fungal spores are resistant to most disinfectants and are persistent problems 
in hospitals. Bacillus and Clostridium are especially difficult to eliminate. 
Concentration or dose of the agent  
Diluting microbicidal chemicals usually weakens their antimicrobial activity. At lower 
concentrations they become microbistatic or lose antimicrobial activity altogether. The 
antimicrobial effects of temperature or radiation also depend on intensity of the exposure. 
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Low dose may inhibit growth, whereas high doses may result in sterilization. With a few 
important exceptions, the more concentrated, the more target organisms will be destroyed. 
Length of exposure 
Microorganisms die when physical or chemical conditions irreversibly damage essential cell 
components. All organisms present, however, do not die rapidly and simultaneously when 
a critical exposure is achieved, because microbial death is a function of time-the longer 
microbes are exposed to potentially lethal conditions, the more microbes will be killed. For 
many germicides, if exposure time is long enough, the probability of even a single cell 
surviving becomes so low that sterilization is practically assured. In contrast, microbistatic 
agents are effective only as long as they are present and must be used during the entire time 
that inhibition is to be maintained. 
Number of microorganisms 
Antimicrobial effectiveness also depends on the initial concentration of the microbial 
population. As the number of microbial contaminants increases, either the exposure period 
to or concentration of the agent must increase to achieve acceptable levels of 
decontamination. 
Environmental conditions  
Temperature, pH, and moisture affect the efficiency of most antimicrobial agents. In 
addition, some chemical agents are absorbed by organic materials (blood, mucus, feces, and 
tissue) that severely reduce antimicrobial effectiveness. These agents therefore cannot be 
used on the skin. Some antimicrobial agents are impeded by soaps and detergents that 
remain as thin films on skin or object surfaces. This difficulty can be avoided by through 
rinsing prior to disinfection or antisepsis. 
Enzybiotics 
The heavy use of antibiotics during the last century has resulted in widespread bacterial 
resistance. Overcoming resistance requires the development of antibiotics aimed at new 
targets in microorganisms. Preferably, such targets should be highly conserved in bacteria 
and required for pathogenesis, but not found in humans. 
One of the most recently delivered classes of antibiotics are enzybiotics, the lytic enzymes 
named because of their enzymatic mode of action in degrading bacteria. Originally, 
enzybiotics named bacteriophage lytic enzymes that destroy the cell wall of the host 
bacterium quickly. According to the nature of bacteriophages that select their host 
specifically, the bacteriophage lytic enzymes were so specific. As the first attempt, Nelson 
and co-workers designate an enzybiotics for fighting with group A Sreptococcus pyogenes (S. 
pyogenes), the primary etiologic agent of bacterial pharyngitis (an inflammation of the throat 
or pharynx). But we must mention that, enzybiotics refer to all kind of enzymes with any 
kind of sources that have the ability to overcome bacterial infection. 
The nick name of enzybiotics is peptidoglycan hydrolyses which induced the enzymatic 
cleavage of peptidoglycan covalent bonds of bacterial cells. As we know, the backbone of 
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peptidoglycan consists of alternating residues of GlcNAc and MurNAc. The tetrapeptide 
side chains branching off from MurNAc are cross-linked by the pentaglycine bridges. This is 
the major mode of enzybiotics action that leads to the hypotonic lysis of poor bacteria by 
degrading different parts of their protective cell wall. Here, we would discuss the well-
known enzybiotics according to, their site of invasion to the peptidoglycan backbone of 
bacteria. 
1. Amidase enzybiotics 
Lysins are the major class of Amidase enzybiotics that work on covalent bonds of bacterial 
peptidoglycan. They are the products of bacteriophages double-stranded DNA and named 
endolysin as a result of their non-bacterial sources. Another class of Amidase enzybiotics is 
autolysins that emerge from host bacterium. Both classes could fall in to three sub-classes 
according to their location of bond cleavage in bacterial peptidoglycan backbone. i) N - 
acetylmuramoyl- L- alanine amidases that break up the covalent bond between MurNAc 
and the first amino acid (L- alanine) of tetrapeptide side chain. ii) endopeptidase that break 
up the covalent bond between internal amino acids of tetrapeptide side chain especially 
between the first L- alaninen and the second D- Glu. Another endopeptidase act on 
pentaglycine bridges and dissociate the internal links of the backbone. iii) the third brother 
enjoy cleavage of covalent bond between N - acetylglucosamine  and N - acetylmuramic acid 
by muramidases, transglycosylases and glucosaminidases activities (Figure1). 
 
Fig. 1. The sites of cleavage by main classes of enzybiotics are shown by the numbered 
arrows  (1) muramidases and transglycosylases; (2) amidases; (3 and 4) endopeptidases; (5) 
glucosaminidases 
One surprise point in applying lysins as new antibiotic is its strain specific function. For 
example Pal only lyses pneumococcal strains while Ply3626 of kills Clostridium  perfringens 
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(C.  perfringens) strains. The most potent lysine discovered in group C streptococci C1 phage 
named PlyC Amidase first reported in 1957. PlyC Amidase is the only known multimeric 
lysine that did not act on streptococci groups B, D, F, G, L, and N so, it is limited to 
pathogenic streptococci groups A and C. Pal1, encoded by pneumococcal bacteriophage Dp-
1, lyses Penicillin-resistant Streptococcus pneumoniae strains as well as penicillin- sensitive 
ones. Cpl-1 muramidase ia another anti-pneumococcal enzyme that came from Cp–1 phage. 
A broad range lysin (PlyGBS lysin) was also reported in Streptococcus agalactiae 
bacteriophage NCTC 1126. PlyGBS lysin contain two endopeptidase and muramidase 
domains that enable it efficient against groups A, C, G, and L streptococci. The other broad 
range lysin that kills groups A, B, C, E, G streptococci and also Enterococcus faecalis is B30 
lysin. B30 lysin also includes two previous domains and extracted from S. agalactiae B30 
phage. Other antibacterial lysins are found in Staphylococcus aureus, coagulase-negative 
staphylococci, Bacillus anthracis, Bacillus cereus, Listeria monocytogenes, C.  perfringens phages 
and one of them (PlyG lysine) is used for the identifi cation of B. anthracis by the U.S. 
Centers for Disease Control and Prevention. 
2. Endopeptidase enzybiotics 
Endopeptidase or endoproteinase are proteolytic peptidases that in contrast to 
exopeptidases, break peptide bonds of nonterminal amino acids. Lysostaphin and zoocin A 
are two endopeptidase encoded by Staphylococcus simulans biovar staphylolyticus and 
Streptococcus  equi ssp. 
3. N-acetylmuramidases enzybiotics 
Lysozymes, or N - acetylmuramidases, are produced by cells of many different animal 
species, plants, insects, bacteria, and viruses. Lysozymes are unique antibiotics, so that they 
contain enzematic and also non-enzematic mechanisms for fighting with foreign bacterias. 
There are some facts about lysosymes take make them so different from other enzybiotics. 
First of all, Lysozymes are the only peptidoglycan hydrolases that have been used on a 
larger scale in humans for the past several decades. Second, antibacterial action of lysozyme 
is based on the enzymatic cleavage of peptidoglycan, and nonenzymatic mechanisms based 
on activation of autolysins and also cytoplasmic membrane destabilization resulting from 
the removal of divalent ions from the membrane surface. 
Plants antibiotics 
Traditionally, people get used to herbal treatment as a natural way to fight diseases almost 
in all continents. Some of them take it easier to go to herbalist than a doctor, and also prefer 
natural drugs than chemically synthesized ones. Especially, in ancient civilizations such as 
Iran, Iraq, India and China it has been so common to use plants as an effective tool for 
diseases therapy. Hippocrates (in the late fifth century B.C.) mentioned 300 to 400 medicinal 
plants. Avicenna (Ibn Sīnā) in his famous book "The Canon of Medicine" lists 800 tested drugs, 
including plant and mineral substances, and describe their specific properties according to 
the known diseases of that time. 
Plants antibiotics come in to view after the arrival of antibiotics in the 1950s, when scientists 
realize that new antibiotics might be obligatory because of the antibiotic resistance. Major 
classes of plants antimicrobial components are phenolics, terpenoids, essential oils, 
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alkaloids, lectins and polypeptide and polyacetylenes. For example, the roots of Glycyrrhiza 
glabra  contain glabridin and hispaglabridin B. The former is active element against both 
Mycobacterium tuberculosis H37Ra and H37Rv strains at 29.16 g/mL concentration. It was 
also clear that, glabridin was more active against Gram-positive strains than Gram-negative. 
Antimycobacterial activity of glabridin like component (hispaglabridin B) did not find 
because of their structural differences. Glabridin have two free phenolic hydroxyls which 
might be crucial in antibacterial activity while hispaglabridin might be inactivated after the 
corporation of one hydroxyl group in protected benzopyrene ring. Methicillin resistant 
Staphylococcus aureus (MRSA), and, Helicobacter pylori (H. pylori) are also sensitive to 
Glabridin. Anti-H. pylori activities are also shown in rachyspermum copticum and Xanthium 
brasilicum with minimum inhibitory concentrations within the range of 31.25-250 micro 
g/ml. 
Grabidin strongly inhibits adenosine 3', 5'-cyclic monophosphate (cAMP) 
phosphodiesterase. Glabridin is associated with reduction in protein kinase C (PKC) activity 
and since PKC is required for low density lipoprotein (LDL) oxidation; so, grabidin induces 
reduction of LDL oxidation. This phenomenon is considered to be of major importance in 
atherosclerosis attenuation because LDL is associated in early atherogenesis. Glabridin can 
inhibit both mono- and diphenolase tyrosinase activities and because of the involvement of 
tyrosinase in melanin biosynthesis, glabridin may serve as candidates for skin-lightening 
agents. On the other hands, grabidin could serve as whitening agents for treatment of 
various dermatological disorders (melasama, age spots, and sites of actinic damage) that 
arise from the excessive accumulation of epidermal pigments. Cytochrome P450 3A4 
enzymes is the major human drug metabolizing enzyme, that inactivated by glabridin 
antioxidant irreversible. The effect on P450 enzymes inactivation may play a role in the 
reported antiatherosclerotic activity of glabridin. 
One of the most exciting plants with antibiotic activity is genus Allium with common garlic 
(Allium sativum L.) that known as Russian penicillin. In a study, two Allioideae alkaloids, 
canthin-6-one and 8-hydroxy-canthin-6-one, are extracted from Allium neapolitanum. They 
displayed minimum inhibitory concentrations (MICs) in the range 8-32 microg/mL against 
a panel of fast-growing Mycobacterium species and 8-64 microg/mL against multidrug-
resistant (MDR) and MRSA. Antibacterial activities of Eucomis autumnalis and Cyathula 
uncinulata against ampicillin-resistant and kanamycin-resistant strains of E.coli revealed a low 
MIC range of 0.27 mg/ml and 0.39 mg/ml respectively. 
New candidate antibiotics for MRSA are from Leguminosae family and the most active ones 
are the flowers of A. auriculiformis and B. kockiana. Some of these medicinal plants, such as B. 
kockiana, B. purpurea, C. pulcherrima, and C. surattensis have been used traditionally to treat 
various diseases in Malaysia. In the case of A. auriculiformis two acylated bisglycoside 
saponins, acaciaside A and B isolated, were found to exhibit antibacterial and antifungal 
activity. 
In a study of resistant and standard strains of Escherichia coli (E. coli), it has been reported 
that Anagyris foetida (Leguminosae) and Lepidium sativum (Umbelliferae) enhanced the 
activity of amoxicillin against resistant E. coli strain. Clarithromycin in combinations with 
Gundelia tournefortii L. (Compositae), Eruca sativa Mill. (Cruciferae), and Origanum syriacum 
L. (Labiateae), shows enhanced activity against the resistant E. coli strain. This strategy, the 
use of herbals and drugs in a multi targeted approach, named "herbal shotgun" or 
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"Synergistic multi-target effects". As a result, herbal-drug combinations affect not one but 
several targets, cooperating in an agonistic-synergistic way. 
Umbelliferae family is known as an herbal antibiotic family after its comparison with 
standard antibiotics. The results show that cefixime and chloramphenicol resistant 
Enterococcus faecalis and Pseudomonas aeruginosa are sensitive to Anethum graveolens, 
Foeniculum vulgare and Trachyspermum ammi. 
In a study of folk medicine, the effects of traditional therapeutic plants used by 
Haudenosaunee peoples of New York State have been administered. Four predicted plants 
(Achillea millefolium, Ipomoea pandurata, Hieracium pilosella, and Solidago canadensis), showed 
antimicrobial properties strongly against Salmonella typhimurium.  
Strong attempts have been performed for treatment of brucellosis, a high morbidity 
zoonosis caused by brucella, with natural antibiotics in Iran. Among four effective herbs 
tasted as antibacterial agents against Brucella melitensis (B. melitensis), Oliveria decumbens was 
chosen as the most effective plant for further studies. A B. melitensis strain that show 
resistance to tetracycline, nafcillin, oxacillin, methicillin, and colistin, inhibited by 
methanolic extract of Oliveria decumbens after 7 hours. Synergistic effect between Oliveria 
decumbens extracts and two other anticiotics (doxycycline and tetracycline) indicated as well.  
Cuminum cyminum L. from Apiaceae family has been used since many years in Iranian 
traditional medicine. This aromatic herb is an astringent that has been used in the treatment 
of mild digestive and bronchopulmonary disorders as well as a cough remedy or analgesic. 
It has been shown that cumin seed essential oil significantly enhance antibacterial efficacy of 
ciprofloxacin against Klebsiella pneumoniae ( K. pneumoniae). The authors theorize that 
essential oil damage cell wall or it modify the outer membrane proteins which lead to 
enhancement of ciprofloxacin activity against K. pneumoniae. As a result, they believe that 
herbal shotgun approach may be used in the case of cumin seed essential oil in future as a 
semi-natural way for fighting with K. pneumoniae related disorders. 
Another medicinal plant that used extremely among Iranian population is Zataria multiflora 
(Z. multiflora) that belongs to the Lamiaceae family. Iranian traditional folk remedies, mainly 
used Z. multiflora as an antiseptic, analgesic, and carminative. In a wide local study of both 
gram-positive and gram-negative bacteria with important clinical impacts, some exciting 
results have been emerged. In the case of gram-positive cocci, and in presence of Z. 
multiflora essential oil (0.44 to 1.41 μL/mL) growth inhibition of both MRSA and MSSA has 
been observed. Same results with higher essential oil MICs have been reported for 
vancomycin-resistant E. faecalis (VREf) and vancomycin-sensitive E. faecalis (VSEf).    
The growth of E. coli O157:H7, the cause of many food-borne outbreaks in different 
countries, inhibited at essential oil concentrations of 0.12 μL/mL for one ecotype of Z. 
multiflora. Two other gram-negative bacteria, Salmonella entrica and Shigella flexneri, inhibited 
and also killed at concentrations ranging from >0.12 to 2 μL/mL. 
A phosphorylated structure, similar to the adenine, was isolated from the berries of Solanum 
incanum (S. incanum) Linnaeus (Thorn Apple or Bitter Apple). It was astonishing that 
crystals of this compound inhibit the growth of gram-positive and gram-negative bacteria, 
yeasts, dermatophytes, and some agricultural pathogens effectively. The zone of inhibition 
for 6.5mm diffusion disks was between 15-26mm with the highest inhibition for S. pyogenes 
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(26mm), C.  perfringens (25mm) and Clostridium septicum (25mm) in bacterial group. It has 
been shown that, S. incanum crystals contain steroidal glycoalkaloids, solanine, which may 
act as a saprogenic surface active agent at high concentration. It must mensioned that 
solanine is found mainly in any part of solanum family plants (solanacea), including the 
leaves, fruit, and tubers and is rather high in the green peel and the sprouts. 
Phage therapy, a candidate for antibiotic replacement 
Phage therapy means the use of lytic bacteriophages as an alternative to antibiotics 
especially against the infection of resistant bacteria. Bacteriophages are bacterial viruses that 
invade bacterial cells and abberated as “phages”. Phages have a developmental cycle within 
the host bacteria which can be lytic or lysogenic. The former involves a series of events that 
lead to the lysis of bacterial cell, but the lysogenic cycle comprises replication of phage 
nucleic acid together with the host genes for several generations. 
There are some important benefits for phage therapy such as host-specific that did not 
observed in the case of routine antibiotics. Bacteriophages specificity could show important 
impacts in clinical use. Another advantages for phage therapy is its lower side effects and 
lesser therapeutic dose according to phages self-replicating in its target bacterial cell. 
Therefore, phage therapy is harmless to the eukaryotic host undergoing therapy 
theoretically.  
Some bacteriophages synthesize degrading enzymes that breakdown the biofilms of bacteria 
that facilitate the bacterial cell lysis. Bacterial resistance to phages, if emerged, could be 
overcome according to the fact that mutation of phages occur with the same rate as bacteria. 
Cheap production of fighting bacteriophages is another advantage of  
It must be mentioned that, phage therapy suffer from serious problems that make it 
unrealable. 
Selection of appropriate mixture of high virulence phages against the target bacteria, poor 
understanding of heterogeneity and ecology of both the phages and the bacteria, are the 
most important problems. Resistance of bacteria to lysis by phages was another important 
challenge especially in the case of Pseudomonas plecoglossicida. 
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